Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iovance Biotherapeutics (IOVA) Other Non-Current Liabilities: 2011-2018

Historic Other Non-Current Liabilities for Iovance Biotherapeutics (IOVA) over the last 2 years, with Dec 2018 value amounting to $230,000.

  • Iovance Biotherapeutics' Other Non-Current Liabilities was N/A to $53,000 in Q3 2019 from the same period last year, while for Sep 2019 it was $53,000, marking a year-over-year change of. This contributed to the annual value of $230,000 for FY2018, which is N/A change from last year.
  • As of FY2018, Iovance Biotherapeutics' Other Non-Current Liabilities stood at $230,000, which was down 97.10% from $7.9 million recorded in FY2011.
  • Iovance Biotherapeutics' Other Non-Current Liabilities' 5-year high stood at $230,000 during FY2018, with a 5-year trough of $230,000 in FY2018.
  • Over the past 1 years, Iovance Biotherapeutics' median Other Non-Current Liabilities value was $230,000 (recorded in 2018), while the average stood at $230,000.